Q2 2023 Holdings
Filed 2023-08-11 | 119 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cava Group Inc(CAVA) | COM | 148929102 | $1.3B | 32,007,990 | 89.3% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $73.5M | 412,496 | 5.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $46.2M | 1,416,031 | 3.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $10.3M | 2,046,517 | 0.7% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $9.7M | 1,000,000 | 0.7% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $3.8M | 500,000 | 0.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.7M | 250,000 | 0.2% |
| Adagene Inc(ADAG) | ADS | 005329107 | $1.5M | 1,000,000 | 0.1% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $1.3M | 10,000 | 0.1% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.1M | 500,000 | 0.1% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $1.0M | 1,133,775 | 0.1% |
| Advanced Micro Devices Inc(AMD) | COM | 007903107 | $683.0K | 6,000 | 0.0% |
| Cyclerion Therapeutics Inc(CYCN) | COM | 23255M204 | $570.0K | 138,403 | 0.0% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $479.0K | 4,000 | 0.0% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $448.0K | 105,347 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $436.0K | 5,028 | 0.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $350.0K | 10,975 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $269.2K | 117,553,284 | 0.0% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $194.0K | 5,440 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $178.0K | 936 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $122.7K | 2,139,995 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $95.7K | 1,050,067 | 0.0% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $83.2K | 1,000,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $74.3K | 2,055,181 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $68.3K | 9,059,507 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $64.2K | 2,401,617 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $57.3K | 4,562,567 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $52.1K | 1,638,858 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $47.6K | 1,816,620 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $41.5K | 1,805,346 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $41.1K | 349,669 | 0.0% |
| Acelyrin Inc | COM | 00445A100 | $38.1K | 1,821,214 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $34.9K | 700,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $25.0K | 15,631,235 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $23.7K | 802,899 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $23.5K | 500,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $23.3K | 2,522,244 | 0.0% |
| Allovir Inc | COM | 019818103 | $22.4K | 6,597,167 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $21.4K | 2,018,056 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $20.4K | 400,000 | 0.0% |
| SEA LTD(SE) | SPONSORED ADS | 81141R100 | $20.3K | 350,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $20.3K | 4,750,000 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $18.0K | 1,911,191 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $17.9K | 5,565,889 | 0.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $16.4K | 1,625,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $15.5K | 2,814,191 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $15.2K | 1,213,725 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $14.9K | 8,589,064 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $14.4K | 765,497 | 0.0% |
| Omega Therapeutics Inc | COM | 68217N105 | $14.2K | 2,533,045 | 0.0% |